EODData

NASDAQ, SABSW:

05 Sep 2025
LAST:

0.0253

CHANGE:
 0.00
OPEN:
0.0260
HIGH:
0.0261
ASK:
0.0000
VOLUME:
52.8K
CHG(%):
3.44
PREV:
0.0262
LOW:
0.0250
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Sep 250.02600.02610.02500.025352.8K
04 Sep 250.02620.02870.02600.026215.5K
03 Sep 250.02560.02560.02560.0256300
02 Sep 250.02550.02550.02550.0255200
29 Aug 250.02810.02810.02810.0281500
27 Aug 250.03010.03250.02800.02805.6K
26 Aug 250.02760.03130.02760.03131.8K
22 Aug 250.02790.02790.02760.027610.8K
21 Aug 250.02750.02750.02500.025132.9K
20 Aug 250.02820.02820.02710.02712.1K

COMPANY PROFILE

Name:
About:SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.
Sector:Healthcare
Industry:Biotechnology
Address:777 W 41st St., Miami Beach, FL, United States, 33140
Website:https://www.sabbiotherapeutics.com
CIK:0001833214
ISIN:US78397T1117
FIGI:BBG00YJ6GDZ7

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:0.10

TECHNICAL INDICATORS

MA5:0.03
MA10:0.03
MA20:0.03
MA50:0.03
MA100:0.03
MA200:0.05
STO9:2.70
STO14:2.70
RSI14:43.96
WPR14:-96.77
MTM14:0.00
ROC14:-0.11
ATR:0.00
Week High:0.03
Week Low:0.03
Month High:0.03
Month Low:0.03
Year High:0.18
Year Low:0.02
Volatility:294.45